'Phase iii trial' presentation slideshows

Moving from Correlative Studies to Predictive Medicine

Moving from Correlative Studies to Predictive Medicine. Richard Simon, D.Sc. Chief, Biometric Research Branch National Cancer Institute http://linus.nci.nih.gov/brb. BRB Website brb.nci.nih.gov. Powerpoint presentations and audio files Reprints & Technical Reports BRB-ArrayTools software

900 views • 89 slides

675 views • 55 slides

667 views • 55 slides

1.09k views • 55 slides

1.16k views • 46 slides

Actinium Pharmaceuticals, Inc.

Actinium Pharmaceuticals, Inc. April 2014 Company Presentation Ticker: ATNM (NYSE MKT).

547 views • 25 slides

Introduction (1)

Phase III trial of chemotherapy with or without irinotecan in the front-line treatment of metastatic colorectal cancer in elderly patients. FFCD 2001-02 trial. Results of a planned interim analysis.

320 views • 19 slides

Total Resection (%) ?

Phase III trial (n=573) ?. Royal Free Hospital (n=84) ?. Median Age (Yrs) ?. 56. 53. Male (%) ?. 64. 65. PS 0-1 (%) ?. 87. 100. Steroid use (%) ?. 67. 88. Biopsy only (%) ?. 16. 49. Partial resection (%) ?. 45. 51. Total Resection (%) ?. 40. 0.

148 views • 1 slides